Xeris Biopharma Announces Research Collaboration and Option Agreement With Horizon Therapeutics plc for XeriJect Formulation of Teprotumumab Read more
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation Read more
Meet AstraZeneca, Johnson & Johnson, Eli Lily and more at the 14th Annual RNA Therapeutics Conference 2023 Read more
Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer Read more
Roche receives U.S. FDA Emergency Use Authorization for its high-throughput test to detect monkeypox virus Read more
Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation for Avacincaptad Pegol for Geographic Atrophy Read more
Phase 3 Trial of ICLUSIG (ponatinib) Met Primary Endpoint in Newly-Diagnosed Ph+ ALL, a Setting with No Targeted Treatments Approved in the US Read more